Each patient need individualised treatment, not only in a type of medication used also in a daily doses, but also it is important to take care about general medical conditions, constitution, educational level, preservation of cognitive abilities, social milieu and family situation. Good and ...
Treatments for Sleep Changes. Web. www.alz.org. Accessed 09 Jan. 2012. http://www.alz.org/alzheimers_disease_10429.asp#treatment Treatments for Alzheimer’s Disease. Web. www. Alz.org. Accessed 09 Jan. 2012. http://www.alz.org/alzheimers_disease_treatments.asp For Edge on Alzhe...
Saved My Life One major indicator of Alzheimer's disease is the loss of brain cells (atrophy). The first area of the brain were atrophy can be detected is in the hippocampus, a horseshoe shaped layer of neurons next to the temporal lobe. This region of the brain is responsible for recent...
Donepezil, therapeutic useAlzheimer's-disease, treatment
Alzheimer's-disease, treatmentHuperzine-A, therapeutic useNeuro-HitechResearch-and-developmentTrial-result-clinical
Family support and involvement are crucial for optimal care. Formulation of advanced directives or an advance proxy plan is important for assuring the patient's previous wishes or best interests are considered when decisions about treatment strategies are made.Psychomotor Agitation...
Galanthamine is a selective acetylcholinesterase inhibitor which has shown potential for the treatment of Alzheimer's disease. Galanthamine is selective for acetylcholinesterase versus butyrylcholinesterase; however, the drug produces greater enzyme inhibition in human erythrocytes than in human brain tissue. ...
Alzheimer's disease (AD) is the most common neurodegenerative cause of dementia and is responsible for significant individual morbidity and mortality, and economic impact on the health care system. Neurodegeneration (includin...
Stress may be involved in the pathogenesis of Alzheimer's disease. There is a heat shock element located at position -317 bp on the beta-amyloid precursor protein (beta-APP) gene promoter. Recently we demonstrated [4] that stress, in the form of heat shock, ethanol and sodium arsenite ...
Fourth, most mild cases of Alzheimer’s dementia do not need treatment in the first place. Finally, people who live around the Mediterranean region have been ingesting saffron for thousands of years, and rates of dementia in these people is no different from what we see in North America. Mor...